• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前胰岛素原特异性CD8 + T细胞在人类1型糖尿病中分泌γ干扰素。

Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes.

作者信息

Rathmann Silvia, Rajasalu Tarvo, Rosinger Silke, Schlosser Michael, Eiermann Thomas, Boehm Bernhard O, Durinovic-Belló Ivana

机构信息

Department of Internal Medicine I, Division of Endocrinology, University of Ulm, Robert-Koch Str. 8, 89081 Ulm, Germany.

出版信息

Ann N Y Acad Sci. 2004 Dec;1037:22-5. doi: 10.1196/annals.1337.004.

DOI:10.1196/annals.1337.004
PMID:15699489
Abstract

In animal models autoreactive CD8(+) T cells are crucial in the development of type 1 diabetes (T1D); however, their role in human T1D is still not known. To address the role of CD81 T cells we performed a pilot study by investigating CD8(+) T cell-mediated cytokine secretion after in vitro stimulation with 94 preproinsulin (PPI) peptides. We were able to show that CD8(+) T cells contribute to a strong IFNgamma reactivity against PPI in human T1D. Further investigations defining epitope specificity, cytokine secretion, and cytotoxic capacity are important to clarify their role in T1D development.

摘要

在动物模型中,自身反应性CD8(+) T细胞在1型糖尿病(T1D)的发病过程中起关键作用;然而,它们在人类T1D中的作用仍不清楚。为了探究CD8(+) T细胞的作用,我们进行了一项初步研究,通过用94种胰岛素原(PPI)肽体外刺激后,研究CD8(+) T细胞介导的细胞因子分泌。我们能够证明,在人类T1D中,CD8(+) T细胞对PPI具有强烈的IFNγ反应性。进一步确定表位特异性、细胞因子分泌和细胞毒性能力的研究,对于阐明它们在T1D发病过程中的作用很重要。

相似文献

1
Preproinsulin-specific CD8+ T cells secrete IFNgamma in human type 1 diabetes.前胰岛素原特异性CD8 + T细胞在人类1型糖尿病中分泌γ干扰素。
Ann N Y Acad Sci. 2004 Dec;1037:22-5. doi: 10.1196/annals.1337.004.
2
Autoreactive T cells in human type 1 diabetes.人类1型糖尿病中的自身反应性T细胞。
Endocrinol Metab Clin North Am. 2004 Mar;33(1):113-33, ix-x. doi: 10.1016/S0889-8529(03)00081-1.
3
Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.糖尿病学会 T 细胞研讨会:HLA Ⅰ类四聚体定向表位验证倡议 T 细胞研讨会报告——HLA Ⅰ类四聚体验证倡议。
Diabetes Metab Res Rev. 2011 Nov;27(8):720-6. doi: 10.1002/dmrr.1243.
4
The importance of CTLA-4 polymorphism and human leukocyte antigen genotype for the induction of diabetes-associated cytokine response in healthy school children.CTLA-4基因多态性和人类白细胞抗原基因型对健康学龄儿童糖尿病相关细胞因子反应诱导的重要性。
Pediatr Diabetes. 2007 Aug;8(4):185-92. doi: 10.1111/j.1399-5448.2007.00245.x.
5
Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.新诊断1型糖尿病成人患者对胰岛素原的体液免疫和细胞免疫反应。
Diabetes Metab Res Rev. 2003 Jan-Feb;19(1):52-9. doi: 10.1002/dmrr.332.
6
Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjects.1型糖尿病患者体内IA-2肽反应性IFNγ+/IL-4- T细胞的频率增加。
J Autoimmun. 2004 Aug;23(1):45-54. doi: 10.1016/j.jaut.2004.03.009.
7
Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.1型糖尿病患儿在诊断时及随访期间对糖尿病相关自身抗原的γ干扰素反应减弱。
Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):462-70. doi: 10.1002/dmrr.639.
8
The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.1型糖尿病诊断和治疗后,胰岛特异性CD8 + T细胞反应的频率和免疫显性会发生变化。
Diabetes. 2008 May;57(5):1312-20. doi: 10.2337/db07-1594. Epub 2008 Feb 27.
9
Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.树突状细胞通过由高风险HLA-DR呈递的受限且独特加工的肽组引导胰岛自身免疫。
J Immunol. 2016 Apr 15;196(8):3253-63. doi: 10.4049/jimmunol.1501282. Epub 2016 Mar 4.
10
Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.在HLA - DRB1*04、DQ8 1型糖尿病中,自身免疫性T细胞针对前胰岛素原产生的促炎和抗炎细胞因子。
Diabetologia. 2004 Mar;47(3):439-450. doi: 10.1007/s00125-003-1315-1. Epub 2004 Jan 24.

引用本文的文献

1
Gene expression pattern in severely progressing covid-19 patients is related to diabetes mellitus type 1: A functional annotation analysis.重症进展期新冠患者的基因表达模式与1型糖尿病相关:一项功能注释分析
Hum Gene (Amst). 2022 Sep;33:201039. doi: 10.1016/j.humgen.2022.201039. Epub 2022 May 10.
2
A Single L/D-Substitution at Q4 of the mInsA Epitope Prevents Type 1 Diabetes in Humanized NOD Mice.mInsA 表位 Q4 处的单个 L/D-取代可预防人源化 NOD 小鼠发生 1 型糖尿病。
Front Immunol. 2021 Aug 30;12:713276. doi: 10.3389/fimmu.2021.713276. eCollection 2021.
3
Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'.
聚焦于抗β细胞特异性T细胞:探寻“作用发生的部位”。
Curr Opin Endocrinol Diabetes Obes. 2017 Apr;24(2):98-102. doi: 10.1097/MED.0000000000000323.
4
Viruses and cytotoxic T lymphocytes in type 1 diabetes.病毒和细胞毒性 T 淋巴细胞在 1 型糖尿病中的作用。
Clin Rev Allergy Immunol. 2011 Oct;41(2):169-78. doi: 10.1007/s12016-010-8220-4.
5
High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK.胰岛素原疏水区和自身抗原区与 70kDa 伴侣蛋白 DnaK 高亲和力结合。
BMC Biochem. 2010 Nov 8;11:44. doi: 10.1186/1471-2091-11-44.
6
Type 1 diabetes mellitus in a child with phenobarbital hypersensitivity syndrome.患有苯巴比妥过敏综合征儿童的1型糖尿病
J Endocrinol Invest. 2008 Apr;31(4):360-3. doi: 10.1007/BF03346371.
7
Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery.人类对胰岛素原前体完整表位集的CD8反应:表位发现方法的启示
J Clin Immunol. 2008 Jul;28(4):350-60. doi: 10.1007/s10875-008-9177-4. Epub 2008 Feb 29.
8
The Development and Application of HLA Tetramers in the Detection, Characterization and Therapy of Type 1 Diabetes Mellitus.HLA四聚体在1型糖尿病检测、特征分析及治疗中的开发与应用
Rev Diabet Stud. 2007 Spring;4(1):56-61. doi: 10.1900/RDS.2007.4.56. Epub 2007 May 10.
9
Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-kappaB.栓木素通过调节转录因子NF-AT和NF-κB来抑制人外周血单个核细胞的增殖。
Br J Pharmacol. 2007 Feb;150(3):298-312. doi: 10.1038/sj.bjp.0706987. Epub 2006 Dec 18.